Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Namba

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Medicine|April 17, 2002
Distinctive gene expression of receptor-type tyrosine kinase families during rat hepatocarcinogenesisHiroaki Kuroda, Akira Ohtsuru, Mitsuru Futakuchi, et al.
Japanese Journal of Ophthalmology|October 2, 2024
Associations of ocular anterior segment structures with sex and age: the Yamagata study (Funagata)Hiroyuki Namba, Naoyuki Maeda, Makoto Tsukamoto, et al.
Cancer Letters|May 26, 2005
Diagnostic usefulness of PCR profiling of the differentially expressed marker genes in thyroid papillary carcinomasAiko Hamada, Svetlana Mankovskaya, Vladimir Saenko, et al.
Thyroid : Official Journal of the American Thyroid Association|January 27, 2005
A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cellsNaomi Hayashida, Hiroyuki Namba, Atsushi Kumagai, et al.
Endocrinology|September 9, 2006
BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activationIryna Palona, Hiroyuki Namba, Norisato Mitsutake, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancersHiroyuki Namba, Masahiro Nakashima, Tomayoshi Hayashi, et al.
Cancer Science|April 24, 2008
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cellsShu Takakura, Norisato Mitsutake, Masahiro Nakashima, et al.
Endocrinology|July 26, 2008
Dehydroxymethylepoxyquinomicin, a novel nuclear Factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastic thyroid cancer cellsZhaowei Meng, Norisato Mitsutake, Masahiro Nakashima, et al.
Oncology Reports|June 21, 2006
Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiationAtsushi Kumagai, Hiroyuki Namba, Norisato Mitsutake, et al.
Biochemical and Biophysical Research Communications|March 27, 2017
Increased interleukin-1β and basic fibroblast growth factor levels in the cerebrospinal fluid during human herpesvirus-6B (HHV-6B) encephalitisMasato Tamai, Nobuyuki Kobayashi, Kazuya Shimada, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Medicine|April 17, 2002
Distinctive gene expression of receptor-type tyrosine kinase families during rat hepatocarcinogenesisHiroaki Kuroda, Akira Ohtsuru, Mitsuru Futakuchi, et al.
Japanese Journal of Ophthalmology|October 2, 2024
Associations of ocular anterior segment structures with sex and age: the Yamagata study (Funagata)Hiroyuki Namba, Naoyuki Maeda, Makoto Tsukamoto, et al.
Cancer Letters|May 26, 2005
Diagnostic usefulness of PCR profiling of the differentially expressed marker genes in thyroid papillary carcinomasAiko Hamada, Svetlana Mankovskaya, Vladimir Saenko, et al.
Thyroid : Official Journal of the American Thyroid Association|January 27, 2005
A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cellsNaomi Hayashida, Hiroyuki Namba, Atsushi Kumagai, et al.
Endocrinology|September 9, 2006
BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activationIryna Palona, Hiroyuki Namba, Norisato Mitsutake, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancersHiroyuki Namba, Masahiro Nakashima, Tomayoshi Hayashi, et al.
Cancer Science|April 24, 2008
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cellsShu Takakura, Norisato Mitsutake, Masahiro Nakashima, et al.
Endocrinology|July 26, 2008
Dehydroxymethylepoxyquinomicin, a novel nuclear Factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastic thyroid cancer cellsZhaowei Meng, Norisato Mitsutake, Masahiro Nakashima, et al.
Oncology Reports|June 21, 2006
Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiationAtsushi Kumagai, Hiroyuki Namba, Norisato Mitsutake, et al.
Biochemical and Biophysical Research Communications|March 27, 2017
Increased interleukin-1β and basic fibroblast growth factor levels in the cerebrospinal fluid during human herpesvirus-6B (HHV-6B) encephalitisMasato Tamai, Nobuyuki Kobayashi, Kazuya Shimada, et al.
Pageof 8